PURE BIOSCIENCE IN (PURE)

0.50
OTC Markets
Prev Close 0.48
Day Low/High 0.50 / 0.53
52 Wk Low/High 0.38 / 1.20
Exchange OTC Markets
Shares Outstanding 68.09B
Market Cap 32.96M
Div & Yield N.A. (N.A)

Latest News

PureCircle Names Stéphane Ducroux Chief Commercial Officer

PureCircle Names Stéphane Ducroux Chief Commercial Officer

CHICAGO, Aug. 21, 2018 /PRNewswire/ -- PureCircle (LSE: PURE), the world's leading producer and innovator of stevia sweeteners, announces the appointment of Stéphane Ducroux as Chief Commercial Officer effective August 16, 2018.

PURE Bioscience Closes On $1.5 Million Financing And Provides Business Update

PURE Bioscience Closes On $1.5 Million Financing And Provides Business Update

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that it has closed on an approximately $1.

IIROC Trading Resumption - PURE

IIROC Trading Resumption - PURE

VANCOUVER, Aug. 16, 2018 /CNW/ - Trading resumes in: Company: Pure Global Cannabis Inc.

IIROC Trading Halt - PURE

IIROC Trading Halt - PURE

VANCOUVER, Aug. 15, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Pure Global Cannabis Inc.

PureCircle Has Vastly Increased Its Capacity To Supply Reb M To The Beverage And Food Industries

PureCircle Has Vastly Increased Its Capacity To Supply Reb M To The Beverage And Food Industries

Enough to Sweeten 500 Million Cases of Carbonated Soft Drinks or the Equivalent Cost Comparable to Sugar CHICAGO, July 12, 2018 /PRNewswire/ -- PureCircle (LSE: PURE), the world's leading producer and innovator of stevia sweeteners, announces that its...

Small-Cap Cannabis Firms Raise Millions in Growth Cash

Small-Cap Cannabis Firms Raise Millions in Growth Cash

Several micro-cap and private companies are pulling in millions in capital as they prepare for the start of legal adult marijuana use in Canada.

IIROC Trading Resumption - PURE

IIROC Trading Resumption - PURE

VANCOUVER, July 10, 2018 /CNW/ - Trading resumes in: Company: PURE GLOBAL CANNABIS INC.

PURE Bioscience Raises $500,000 In Unsecured Promissory Note - Appoints Ivan Chen To Board Of Directors

PURE Bioscience Raises $500,000 In Unsecured Promissory Note - Appoints Ivan Chen To Board Of Directors

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that it has raised $500,000 in the form of a promissory note from Tom Lee, a member of PURE's Board of Directors and...

PURE Bioscience Reports Fiscal 2018 Third Quarter And Nine-Month Financial Results

PURE Bioscience Reports Fiscal 2018 Third Quarter And Nine-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month period ended April 30, 2018.

PURE Bioscience Responds To The Latest Foodborne Illness Outbreak Tied To Romaine Lettuce

PURE Bioscience Responds To The Latest Foodborne Illness Outbreak Tied To Romaine Lettuce

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today responded to the current widespread foodborne illness outbreak associated with romaine lettuce.

PURE Bioscience Reports Fiscal 2018 Second Quarter And Six-Month Financial Results

PURE Bioscience Reports Fiscal 2018 Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month period ended...

PURE Bioscience Sets Fiscal 2018 Q2 Financial Results Conference Call

PURE Bioscience Sets Fiscal 2018 Q2 Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on March 14, 2018 the Company will file its Form 10-Q shortly after the close of...

PURE Bioscience Provides Update: Expanding Use Of PURE Control® Antimicrobial In Produce Processing; Expanding Use Of PURE® Hard Surface Disinfectant

PURE Bioscience Provides Update: Expanding Use Of PURE Control® Antimicrobial In Produce Processing; Expanding Use Of PURE® Hard Surface Disinfectant

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, provided an update on the expanded use of FDA approved PURE Control® antimicrobial for...

PURE Bioscience To Present At The 30th Annual ROTH Capital Partners Conference

PURE Bioscience To Present At The 30th Annual ROTH Capital Partners Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company will present at the 30th Annual ROTH Capital Partners Conference on...

PURE Bioscience Receives Initial Orders From Leading Foodservice Distributor For PURE® Hard Surface Food Transport Sanitization Solution

PURE Bioscience Receives Initial Orders From Leading Foodservice Distributor For PURE® Hard Surface Food Transport Sanitization Solution

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that a leading foodservice distributor has placed initial orders for PURE® Hard...

PURE Bioscience Reports Fiscal 2018 Q1 Financial Results

PURE Bioscience Reports Fiscal 2018 Q1 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2017.

PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call

PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 14, 2017 the Company will file its Form 10-Q shortly after the close...

PURE Bioscience To Present At The 10th Annual LD Micro Conference

PURE Bioscience To Present At The 10th Annual LD Micro Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that Hank R.

PURE Bioscience Expands Board Of Directors With Appointment Of Elisabeth Hagen, M.D., Food Safety Consultant

PURE Bioscience Expands Board Of Directors With Appointment Of Elisabeth Hagen, M.D., Food Safety Consultant

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that it has named Elisabeth Hagen, M.

PURE Bioscience Reports Fiscal 2017 Year-End Financial Results

PURE Bioscience Reports Fiscal 2017 Year-End Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2017.

PURE Bioscience Announces Partnership With IGPS Logistics

PURE Bioscience Announces Partnership With IGPS Logistics

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that it has signed an agreement with, and received an initial order from, iGPS...

PURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control® Antimicrobial

PURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control® Antimicrobial

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that PURE Control® antimicrobial processing aid achieved strong results during...

PURE Bioscience Completes Successful Warrant Tender Offer And Raises $2.8 Million From Exercise Of Warrants

PURE Bioscience Completes Successful Warrant Tender Offer And Raises $2.8 Million From Exercise Of Warrants

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that on October 10, 2017 it successfully completed a tender offer to amend and...

PURE Bioscience To Host Fiscal 2017 Year-End Financial Results Conference Call

PURE Bioscience To Host Fiscal 2017 Year-End Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that on October 26, 2017 the Company will file its Form 10-K shortly after the close...

PURE Bioscience To Present At 2017 SeeThru Equity Investor Conference

PURE Bioscience To Present At 2017 SeeThru Equity Investor Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the 2017 SeeThru Equity Investor Conference at 11am...

PURE Control® Antimicrobial Listed As Safe And Suitable Ingredient In The USDA-FSIS Directive 7120.1 For Poultry Products

PURE Control® Antimicrobial Listed As Safe And Suitable Ingredient In The USDA-FSIS Directive 7120.1 For Poultry Products

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that PURE Control® antimicrobial is included in the newly updated list of Safe and...

PURE Bioscience To Present At 2017 Southern California Investor Conference

PURE Bioscience To Present At 2017 Southern California Investor Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the 2017 Southern California Investor Conference on...